
Tags Archive Navigation
icon
-
StoryCompassionate use: Providing access to much needed treatments
-
StoryRenewing our commitment to neglected tropical disease and malaria elimination
-
StoryWhen it comes to cancer, there’s power in a good partner
-
Media ReleaseNovartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
-
Media ReleaseNovartis announces data showing Jakavi® (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease
-
StoryToward improving the health and longevity of transplanted organs
-
StoryResearchers boost understanding of T-cell therapy in blood cancer
-
StoryGoing the extra mile to keep clinical trials on track during the COVID-19 pandemic
-
StoryPutting patients first
-
StoryCancer didn’t stop for COVID-19
-
StoryRediscovering the power of nature’s exquisite complexity
-
StoryOpening chemistry education to the world